🇺🇸 FDA

Company profile · Sponsor

Intrabio

Intrabio Ireland Limited

E49BC64 · EMA pharma GB
Pipeline
3
Drugs
0
Patents
0

Quick answer

Intrabio (E49BC64) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E49BC64
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (3)

Search pipeline →

  1. Granules for oral suspension, N-Acetyl-L-Leucine

    Intrabio

    Niemann-Pick disease type C

    phase 3 small molecule active

    1 trial

  2. N-Acetyl-L-Leucine, granules for suspension

    Intrabio

    CACNA1A Disorders

    phase 3 small molecule active

    1 trial

  3. granules for suspension, N-Acetyl-L-Leucine

    Intrabio

    Ataxia Telangiectasia

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Intrabio?

Intrabio (E49BC64) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Intrabio sponsor?

We track 3 ClinicalTrials.gov-linked programs for Intrabio, including Granules for oral suspension, N-Acetyl-L-Leucine and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Intrabio company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.